Skip to content
Review

Polygenic Risk Scores: Towards Clinical Application.

Oct 2026 · Deutsches Ärzteblatt International · Vol 123 22 · 0 citations
Medicine

TL;DR

The current state of bench-to-bedside translation of polygenic risk scores (PRS) is reviewed and it is shown that quality standards must be established to ensure that the potential of PRS can be effectively translated into routine clinical practice.

View source

Similar papers

Review Sep 2026

Clinical Uses of Common Genetic Variants Associated with Common Diseases.

Twenty-five years after the draft of the human genome sequence, genomics has revolutionized many areas of biology, the diagnosis of familial and early-onset diseases, and the development of targeted therapies, particularly in oncology. Genomic knowledge has had little effect on the diagnosis and treatment of most commo...

David J. Hunter, Michael Inouye · 0 citations
Review Open access Sep 2026

Polygenic risk scores in human genetics for study design discovery and translation

This review outlines four major PRS-informed design strategies: tail sampling based on PRS extremes; discordance sampling based on mismatch between phenotype and PRS-implied risk; conditional and stratified genome-wide association analyses using PRS to adjust for / partition background risk; and residual phenotype anal...

Hui-Qi Qu, H. Hakonarson · 0 citations
Review Open access Aug 2026

Polygenic risk score and its role in cancer susceptibility.

BACKGROUND Polygenic risk score (PRS) has the ability to stratify inherited susceptibility to cancer and, as a complement to monogenic testing, can identify individuals at increased genetic risk even when no pathogenic variant is detected in high- or moderate-penetrance genes. It reflects the combined additive effects...

Adéla Mišove, E. Macháčková, Klára Nováková et al. · 0 citations
Open access Aug 2026

Polygenic risk score for early identification of coronary artery disease in a real-world clinical setting within the Latvian patient population

Study objective Polygenic risk scores (PRS) are increasingly recognized for their potential to improve coronary artery disease (CAD) prediction beyond traditional clinical models. This study evaluated the utility of genome-wide association study (GWAS) - derived PRS and pathway-specific PRS (PS-PRS) in the Latvian popu...

E. Kanašniece, Elita Ozola, L. Bardina et al. · 0 citations
Open access Sep 2026

Established polygenic risk score for hypercholesterinemia demonstrates discriminatory value and risk stratification in an independent German Cohort

Polygenic risk scores (PRS) have emerged as promising tools for stratifying inherited disease risk, yet their translation into clinical practice is constrained by a critical and frequently unmet requirement: demonstration that scores derived in one cohort retain discriminatory value when applied independently in a diff...

L. Bundalian, A. Velluva, E. Gjermeni et al. · 0 citations
Open access Sep 2026

Genetic risk stratification of common diseases in breast cancer survivors: a population-based cohort study.

IMPORTANCE Patients diagnosed with breast cancer (BCa) are at increased risk of multiple common diseases; however, the spectrum of these diseases and the contribution of inherited genetic susceptibility remain incompletely characterized. METHODS We evaluated 15 common diseases and tested their associations with BCa e...

Annabelle Ashworth, Zhu-Qing Shi, Huy Tran et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.